PubMed:1782151 / 495-574 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/1782151","sourcedb":"PubMed","sourceid":"1782151","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/1782151","text":"IFN primed, cycloheximide/polyinosinic-polycytidylic acid treated HeLa S3 cells","tracks":[{"project":"jnlpba-st-training","denotations":[{"id":"T11","span":{"begin":0,"end":79},"obj":"cell_line"}],"attributes":[{"subj":"T11","pred":"source","obj":"jnlpba-st-training"}]},{"project":"genia-medco-coref","denotations":[{"id":"C8","span":{"begin":0,"end":79},"obj":"NP"}],"attributes":[{"subj":"C8","pred":"source","obj":"genia-medco-coref"}]},{"project":"GENIAcorpus","denotations":[{"id":"T14","span":{"begin":0,"end":3},"obj":"protein_molecule"},{"id":"T15","span":{"begin":12,"end":57},"obj":"other_organic_compound"}],"attributes":[{"subj":"T14","pred":"source","obj":"GENIAcorpus"},{"subj":"T15","pred":"source","obj":"GENIAcorpus"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"jnlpba-st-training","color":"#e1ec93","default":true},{"id":"genia-medco-coref","color":"#dd93ec"},{"id":"GENIAcorpus","color":"#93ecc3"}]}]}}